Health on MSN10h
Study Offers More Evidence That Ozempic Could Cause Hair Loss
Taking medications like Ozempic and Wegovy may lead to more hair loss than other weight loss drugs, new research found.
Asianet Newsable on MSN1h
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars
Vivani Medical, Inc. (VANI), on Wednesday, announced promising preclinical data for its semaglutide implant in development ...
TMCnet15h
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...
New Scientist16h
Why exercise is more important than ever when taking weight-loss drugs
GLP-1 drugs have revolutionised the treatment of obesity, but the very reason they are effective is also why it's vital to ...
Cheaper and More Effective: New MIT Breakthrough Could Improve Popular Weight Loss Drugs Such As Ozempic
MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...
Study links Wegovy to increased hair loss risk
Researchers assessed data from 16 million patients from 2006 to 2020 taking semaglutide-based drugs; the active ingredient in Wegovy.
Novo Nordisk Stock Sinks To 52-Week Lows: Weight Loss Boom Losing Steam?
Novo Nordisk is betting on the future with a $2-billion deal to buy rights to a Chinese obesity drug. But investors remain unimpressed.